Verastem Oncology
VSTM
#7631
Rank
NZ$0.48 B
Marketcap
$9.40
Share price
-6.16%
Change (1 day)
-51.31%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -NZ$0.23 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are NZ$10 Million. a decrease over its 2023 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.23 Billion49.31%
2023 -NZ$0.15 Billion18.36%
2022 -NZ$0.13 Billion3.67%
2021 -NZ$0.13 Billion5.43%
2020 -NZ$0.12 Billion-54.74%
2019 -NZ$0.26 Billion105.99%
2018 -NZ$0.13 Billion6.83%
2017 -NZ$0.12 Billion86.06%
2016 -NZ$62.49 Million-37.03%
2015 -NZ$99.23 Million8.43%
2014 -NZ$91.51 Million29.52%
2013 -NZ$70.65 Million28.6%
2012 -NZ$54.94 Million133.9%
2011 -NZ$23.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$76.84 Million-65.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.05 B-8,618.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.00 B-995.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.53 B-3,468.70%๐Ÿ‡ฌ๐Ÿ‡ง UK